{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T17:28:18Z","timestamp":1763141298433,"version":"3.37.3"},"reference-count":39,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Science and Technology Project of Beijing","award":["D171100002817003","D171100002817002"],"award-info":[{"award-number":["D171100002817003","D171100002817002"]}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"publisher","award":["2016YFC1305500"],"award-info":[{"award-number":["2016YFC1305500"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"name":"China Health Promotion Foundation","award":["2018\u20132022"],"award-info":[{"award-number":["2018\u20132022"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chronic Diseases and Translational Medicine"],"published-print":{"date-parts":[[2020,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Tripterygium glycosides (TGs) have been widely used in China to treat diabetic nephropathy (DN); however, proof of their use is scarce. The present study aimed to evaluate the effectiveness and safety of adding TGs to angiotensin\u2010converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>By searching Embase, MEDLINE, Cochrane Library, SINOMED, China National Knowledge Infrastructure, VIP Information\/Chinese Scientific Journals, and WANFANG databases, we identified previous studies that met the specific selection criteria and included them in the meta\u2010analysis. Analyses were performed using Review Manager (version 5.3).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Nine randomized controlled trials were included in the final meta\u2010analysis. Patients were compared before and after treatment with ACE inhibitors or ARBs plus TGs, or ACE inhibitors or ARBs alone. The results revealed that treatment with ACE inhibitors or ARBs plus TGs resulted in significantly greater reductions in 24\u2010h urinary total protein (UTP) levels (trial duration\u00a0&lt;2 months, mean difference [MD]: \u22120.25; 95% confidence interval [<jats:italic>CI<\/jats:italic>]: \u22120.32, \u22120.18; trial duration between 2 and 6 months, MD: \u22120.39; 95% <jats:italic>CI<\/jats:italic>: \u22120.44, \u22120.33; trial duration\u00a0&gt;6 months, MD: \u22122.09; 95% <jats:italic>CI<\/jats:italic>: \u22122.89, \u22121.29) compared with treatment using ACE inhibitors or ARBs alone. Additionally, ACE inhibitors or ARBs plus TGs showed better results after long\u2010term administration. Treatment with ACE inhibitors or ARBs plus TGs resulted in significantly greater reductions in serum creatinine (SCr) compared with ACE inhibitors or ARBs alone (MD: \u22129.87; 95% <jats:italic>CI<\/jats:italic>: \u221213.76, \u22125.97).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In patients with DN, adding TGs to ACE inhibitors or ARBs significantly lowered both the 24\u2010h UTP and SCr levels. Therefore, ACE inhibitors or ARBs plus TGs might improve the treatment of DN in patients.<\/jats:p><\/jats:sec>","DOI":"10.1016\/j.cdtm.2019.12.008","type":"journal-article","created":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T22:13:28Z","timestamp":1581372808000},"page":"18-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effects of adding tripterygium glycosides to angiotensin\u2010converting enzyme inhibitors or angiotensin receptor blockers on albuminuria in patients with diabetic nephropathy"],"prefix":"10.1002","volume":"6","author":[{"given":"Jin\u2010Ying","family":"Fang","sequence":"first","affiliation":[{"name":"Beijing University of Chinese Medicine Beijing 100029 China"},{"name":"Department of Nephrology China\u2010Japan Friendship Hospital Beijing 100029 China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Nephrology China\u2010Japan Friendship Hospital Beijing 100029 China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Nephrology China\u2010Japan Friendship Hospital Beijing 100029 China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi\u2010Min","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Nephrology China\u2010Japan Friendship Hospital Beijing 100029 China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian\u2010Yu","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Nephrology China\u2010Japan Friendship Hospital Beijing 100029 China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen\u2010Ge","family":"Li","sequence":"additional","affiliation":[{"name":"Beijing University of Chinese Medicine Beijing 100029 China"},{"name":"Department of Nephrology China\u2010Japan Friendship Hospital Beijing 100029 China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2020,3]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-1296"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-011-0510-5"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60033-6"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60439-0"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-018-2305-7"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204807"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep09700"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/429878"},{"key":"e_1_2_10_10_1","first-page":"159","article-title":"Decreased bone mineral density in female patients with systemic lupus erythematosus after long\u2010term administration of Tripterygium Wilfordii Hook","volume":"113","author":"Huang L.","year":"2000","journal-title":"F Chin Med J (Engl)"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2017.3068"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1179\/1528433614Z.0000000005"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1159\/000083980"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/390428"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/17.4.597"},{"key":"e_1_2_10_16_1","first-page":"ED000142","article-title":"Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions","volume":"10","author":"Cumpston M.","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_10_17_1","unstructured":"H.JPTGS.Cochrane Handbook for Systematic Reviews of Interventions.2011 version 5.1.0http:\/\/www.cochraneorg\/handbookCochraneHandbook"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2535"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1186"},{"key":"e_1_2_10_20_1","first-page":"1149","article-title":"Effects of irbesartan combined with tripterygium wilfordii on urinary protein in patients with diabetic nephropathy in highland areas (in Chinese)","volume":"28","author":"Chen H.","year":"2012","journal-title":"Clin Med Chin"},{"key":"e_1_2_10_21_1","first-page":"416","article-title":"Effect of triptolide on urinary monocyte chemottractant protein\u20101 in patients with diabetic nephropathy (in Chinese)","volume":"25","author":"Song H.X.","year":"2005","journal-title":"Chin J Integr Tradit West Med"},{"key":"e_1_2_10_22_1","first-page":"212","article-title":"The effect of tripterygium wilfordii combined with benazeprilon proteinuria in diabetic nephropathy (in Chinese)","volume":"37","author":"HeJM","year":"2016","journal-title":"Guangdong Med J"},{"key":"e_1_2_10_23_1","first-page":"73","article-title":"Effect of tripterygium glycosides and irbesartan on type 2 diabetic nephropathy (in Chinese)","volume":"9","author":"Zhang Y.J.","year":"2012","journal-title":"Chin Med Herald"},{"key":"e_1_2_10_24_1","first-page":"1527","article-title":"Effects of tripterygium glycosides combined with telmisartan on renal function and hemorheology in patients with diabetic nephropathy (in Chinese)","volume":"15","author":"Tu C.F.","year":"2017","journal-title":"Chin J Gen Pract"},{"key":"e_1_2_10_25_1","first-page":"753","article-title":"Effect of tripterygium glycosides combined with valsartan on proteinuria in stage IV diabetic nephropathy (in Chinese)","volume":"18","author":"Wu Y.P.","year":"2018","journal-title":"Chin Remedies Clin"},{"key":"e_1_2_10_26_1","first-page":"248","article-title":"Tripterygium glycosides tablets in the treatment of 66 cases of diabetic nephropathy in stage IV (in Chinese)","volume":"2","author":"Zhang H.C.","year":"2015","journal-title":"Chin Pharm"},{"key":"e_1_2_10_27_1","first-page":"1048","article-title":"Clinical efficacy of tripterygium wilfordii combined with irbesartan in the treatment of early and middle stage diabetic nephropathy (in Chinese)","author":"Li Z.X.","year":"2015","journal-title":"J Clin Res"},{"key":"e_1_2_10_28_1","first-page":"154","article-title":"Effect of valsartan dispersible tablets and tripterygium wilfordii on proteinuria in diabetic nephropathy (in Chinese)","volume":"22","author":"Song M.A.","year":"2014","journal-title":"China Med Eng"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2014.06.006"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2016.1132306"},{"key":"e_1_2_10_31_1","first-page":"152","article-title":"Clinical observation 48 cases of elderly\u2010onset rheumatoid arthritis treating with Tripterygium glycoside combined with leflunomide (in Chinese)","volume":"20","author":"Long H.","year":"2014","journal-title":"Contemp Med"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-006-0080-1"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2005040393"},{"key":"e_1_2_10_34_1","first-page":"S42","article-title":"Comprehensive two\u2010dimensional liquid chromatography coupled to triple quadrupole mass spectrometry: application to a challenging food case study","volume":"32","author":"Giuffrida D.","year":"2014","journal-title":"LC GC Eur"},{"key":"e_1_2_10_35_1","first-page":"499","article-title":"Effect of Tripterygium glycosides on expression of hypoxia inducible factor\u20101\u03b1 and endothelin\u20101 in kidney of diabetic rats (in Chinese)","volume":"35","author":"Chen W.D.","year":"2015","journal-title":"J South Med Univ"},{"key":"e_1_2_10_36_1","first-page":"817","article-title":"Preventive effect of multi\u2010glycoside of tripterygium Wilfordii Hook. f. on proteinuria and mesangial injury in experimental mesangial proliferative glomerulonephritis (in Chinese)","volume":"25","author":"Wan Y.G.","year":"2005","journal-title":"Chin J Integr Tradit West Med"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2013.12.005"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2008.203"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2018.11.031"},{"key":"e_1_2_10_40_1","first-page":"3100","article-title":"Systematic evaluation for efficacy of tripterygium glycosides in treating diabetic nephropathy stage IV (in Chinese)","volume":"40","author":"Huang J.","year":"2015","journal-title":"China J Chin Mater Med"}],"container-title":["Chronic Diseases and Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095882X19300945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095882X19300945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1016\/j.cdtm.2019.12.008","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1016\/j.cdtm.2019.12.008","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1016\/j.cdtm.2019.12.008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T02:17:10Z","timestamp":1693102630000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1016\/j.cdtm.2019.12.008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["10.1016\/j.cdtm.2019.12.008"],"URL":"https:\/\/doi.org\/10.1016\/j.cdtm.2019.12.008","archive":["Portico"],"relation":{},"ISSN":["2589-0514","2589-0514"],"issn-type":[{"type":"print","value":"2589-0514"},{"type":"electronic","value":"2589-0514"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of adding tripterygium glycosides to angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on albuminuria in patients with diabetic nephropathy","name":"articletitle","label":"Article Title"},{"value":"Chronic Diseases and Translational Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cdtm.2019.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Chinese Medical Association. Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.","name":"copyright","label":"Copyright"}]}}